Dr Judy Chou, CEO, President and Board Member of AltruBio, Inc, explains how agonist antibodies show potential as a novel therapeutic approach in immunological diseases.

Anirban Datta, Head of Discovery Biology at Verseon International Corporation, details recent breakthroughs in organoid ...

In this article, Dr Raminderpal Singh speaks to Janette Thomas of Five Alarm Bio for a biotech CEO’s perspective on the ...

Disrupting F-actin in aged brains restored brain autophagy to youthful levels and reversed some cellular markers of brain ...

Amidst a new wave of innovation in antibody research, this report highlights recent breakthroughs across fields such as ...

The self-assembly of human liver tissues in low Earth orbit could improve their differentiation and functionality.

Researchers reveal that GPNMB could be an effective therapeutic agent to improve cardiac function and prevent heart failure.

In this Q&A, Simon Lovestone, Vice President, Global Head, Neuroscience Discovery and Translational Science at Johnson & ...

Small molecules are essential for developing effective medicines, but their structural complexity and material behaviour ...

The glaucoma drug methazolamide removed tau build-up and lessened signs of dementia in genetically-engineered zebrafish and mice.

Altered RNA processing is highly damaging to neurons, adding a new toxic component to the evolution of AD. Currently, the ...

We had the privilege of talking to Veerle d’Haenens, General Manager, Global Therapy Innovations at Terumo Blood and Cell ...